Form 4 for VERA Vera Therapeutics, Inc.
Accepted 2025-12-04 00:00:00 ET · period of report 2025-12-03 · accession 0001193125-25-308074 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-12-04 | 2025-12-03 | VERA | Turner William D. | Chief Regulatory Off | S - Sale+OE | $40.00 | -10.0K | 22.5K | -31% | -$400.0K |
| DT | 2025-12-04 | 2025-12-03 | VERA | Turner William D. | Chief Regulatory Off | M - OptEx | $15.53 | +10.0K | 32.5K | +44% | +$155.3K |
| DT | 2025-12-04 | 2025-12-03 | VERA | Turner William D. | Chief Regulatory Off | M - OptEx | $0.00 | -10.0K | 265.0K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-12-03 | S | D | 10,000 | $40.00 | 22,500 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-12-03 | M | A | 10,000 | $15.53 | 32,500 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2025-12-03 | M | D | 10,000 | $0.00 | 265,000 | D | $15.53 · — to 2034-01-04 | 10,000 Class A Common Stock | (F2) 1/4 of the shares subject to the option vested on January 5, 2025, and 1/48 of the shares vest monthly thereafter, subject to continuous service of the Reporting Person through each vesting date. |